Globus Medical completed its acquisition of Nevro, a spinal cord stimulator company, according to an April 3 news release.
The acquisition expands Globus Medical’s reach in the musculoskeletal market and the opportunity to add to its product portfolio.
The deal was first announced in February, and Nevro was valued at $250 million. Nevro employs HFX spinal cord stimulation, which is used in its Senza SCS system. The company also offers minimally invasive treatments for chronic sacroiliac joint pain.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
